Awakn Life Sciences Corp.: Awakn Life Sciences Signs Agreeme

Agreement Provides 12-Month Exclusive Period to Agree in-Licensing Deal for Proprietary Formulation of Ketamine
Toronto, Ontario--(Newsfile Corp. - August 25, 2022) - Awakn Life Sciences Corp. (NEO: AWKN)

Related Keywords

United Kingdom , United States , Canada , Toronto , Ontario , America , Gordo Whittaker , Anne Donohoe , Tesfa Mekonen , Anthony Tennyson , Linkedin Facebook , Awakn Life Sciences , Strategic Communications , Newsfile Corp , Awakn Life Sciences Corp , Agreement Provides , Month Exclusive Period , Licensing Deal , Proprietary Formulation , Life Sciences , Alcohol Use Disorder , Project Kestrel , Awakn Life , United States Securities Act , Global Burden , Alcohol Use Disorders , Alcohol Liver , Awakn , Life , Ciences , Orp , Signs , Agreement , Reading , Drug , Development , Company , Eepen , Boat , Head , Program ,